Suma Krishnan sold $11M of KRYS
President, R&D at Krystal Biotech, Inc.. 50,000 shares at an average of $220.15, traded Dec 4, 2025, filed Dec 5, 2025.
Score components
- +20RolePresident
- +25Trade size$11.0M at market
- 0Share of holdings soldSold 3.5% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001298711-25-000013, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 4, 2025 | SOpen-market sale Common Stock10b5-1 | -700 | $214.25 | $150k | 1,438,011 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stock10b5-1 | -600 | $215.49 | $129k | 1,437,411 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stock10b5-1 | -1,400 | $216.97 | $304k | 1,436,011 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stock10b5-1 | -3,593 | $218.83 | $786k | 1,432,418 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stock10b5-1 | -5,419 | $219.68 | $1.2M | 1,426,999 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stock10b5-1 | -2,627 | $220.52 | $579k | 1,424,372 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stock10b5-1 | -10,461 | $221.82 | $2.3M | 1,413,911 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stock10b5-1 | -200 | $222.38 | $44k | 1,413,711 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -956 | $214.28 | $205k | 1,507,100 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -344 | $215.48 | $74k | 1,506,756 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -1,600 | $217.04 | $347k | 1,505,156 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -2,577 | $218.72 | $564k | 1,502,579 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -5,693 | $219.53 | $1.2M | 1,496,886 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -2,625 | $220.34 | $578k | 1,494,261 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -10,505 | $221.78 | $2.3M | 1,483,756 | Dec 5, 2025 |
| Dec 4, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -700 | $222.20 | $156k | 1,483,056 | Dec 5, 2025 |
| Dec 5, 2025 | GGift Common Stockindirect: By Spouse10b5-1 | -5,000 | $0.00 | $0 | 1,478,056 | Dec 5, 2025 |
Related signals
Other insiders at Krystal Biotech, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $9.0M 25,000 shares | -2% | |
| 33Weak | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $9.0M 25,000 shares | -2% | |
| 45Moderate | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $6.6M 25,000 shares | -2% | |
| 40Moderate | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $6.6M 25,000 shares | -2% | |
| 40Moderate | Krystal Biotech, Inc. | Daniel Janney director | $3.3M 11,803 shares | -14% | |
| 7Weak | Krystal Biotech, Inc. | Kathryn Romano Chief Accounting Officer | $201k 750 shares | -3% | |
| 40Moderate | Krystal Biotech, Inc. | Daniel Janney director | $16M 60,161 shares | -159% | |
| 45Moderate | Krystal Biotech, Inc. | Dino A Rossi director | $5.0M 18,950 shares | -19% | |
| 23Weak | Krystal Biotech, Inc. | Kathryn Romano Chief Accounting Officer | $3.4M 12,500 shares | -39% | |
| 38Weak | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $11M 50,000 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.